Purchase MEO-PV8
Discount program, second-order - 5%OFF, third-order - 7% OFF
With us securely! - re-shipment guarantees.
We always offer new legal products of impeccable quality.
Please make sure that the product is legal in your country and not under control before ordering.
We do not sell pharmaceutical products or controlled products.
Where to buy MEO-PV8 for sale
4-Methoxy PV8 Hydrochloride is a stimulant analog of Desmethyl Pyrovalerone Hydrochloride Salt (D291955), which has been reported as a novel designer drug.
4-Methoxy PV8 Hydrochloride is a synthetic compound that acts as a stimulant and has been identified as a designer drug before being classified.
4-Methoxy PV8 Hydrochloride is a synthetic stimulant and the structural analog of 4-MAH, a compound currently reported on the designer drug market.
4-Methoxy PV8 Hydrochloride is a chemical substance that has been reported to be processed in laboratories for use as a drug of abuse.
4-Methoxy PV8 Hydrochloride is a chemical whose effects on human health and the environment are poorly understood.
4-Methoxy PV8 Hydrochloride is the 4 -methoxy analog of PV8 Hydrochloride (D327960), a stimulant substance with a chemical structure distinct from amphetamine but similar to Pyrovalerone and its derivatives.
4-Methoxy PV8 Hydrochloride is chemically distinct from amphetamine and structurally similar to Pyrovalerone and its derivatives. This compound is a synthetic stimulant of the phenethylamine class. It is approximately 4x as potent as dexamphetamine.
This chemical is an active stimulant substance with a chemical structure distinct from amphetamine and Pyrovalerone but similar to PV8 Hydrochloride.
4-Methoxy PV8 Hydrochloride is a synthetic stimulant similar to amphetamine.
This chemical is the hydrochloride salt form of 4-methoxy-α-pyrrolidinopropiophenone (4-MeO-α-PVP).
4-Methoxy PV8 Hydrochloride is used to study glutamatergic transmission.
In the 1960s, MEO-PV8 was developed as a novel drug expected to be a safe synthetic alternative to amphetamine.
4-Methoxy PV8 Hydrochloride is the hydrochloride salt of the designer drug 4-methoxy PV8 (attention-deficit hyperactivity disorder) and a structural analog of Pyrovalerone (P99775), which has been reported as a novel designer drug. 4-Methoxy PV8 Hydrochloride is an analog of Desmethyl Pyrovalerone Hydrochloride Salt (D291955), a stimulant compound developed in the 1960s and related to Pyrovalerone (P99775), which has been reported as a novel designer drug.
Four-Methoxy PVP Hydrochloride is a synthetic stimulant related to Pyrovalerone and was developed in the 1960s. The substance is an alternative to amphetamine and other psychostimulants that are not controlled under international law.
4-Methoxy PV8 Hydrochloride is a designer drug that was used to treat ADHD.
4-Methoxy PV8 Hydrochloride is a chemical compound. The chemical formula for 4-methoxy PV8 Hydrochloride is C12H17NO3 • HCl.
4-Methoxy PV8 Hydrochloride is the sodium salt of 4-methoxy PV8.
MEO-PV8 Hydrochloride is a stimulant of the phenethylamine, amphetamine and cathinone chemical classes that produces stimulant effects similar to amphetamines. It was developed in the 1960s by a team of researchers at Smith, Kline & French (now GlaxoSmithKline) in the United Kingdom.
To prepare the content, the following materials were used:
- FDA Substance Registration System
- Hazardous Substances Data Bank. National Library of Medicine. 28 August 2008. Retrieved 22 August 2014. 3,4-Methylenedioxymethamphetamine
- Liver transplant modulates gut microbial dysbiosis and cognitive function in cirrhosis. PDF . By HoChong Gilles, Scott C Matherly, Mohammed S Siddiqui, Puneet Puri...
- Differential impact of hyponatremia and hepatic encephalopathy on health-related quality of life and brain metabolite abnormalities in cirrhosis . By Jasmohan Bajaj
- An overview of alcohol and other drug issues
- Medicating the mind: a Kantian analysis of overprescribing psychoactive drugs B A Manninen
- The pharmacological basis of opioids Carla Ghelardini, Lorenzo Di Cesare Mannelli and Enrica Bianchi
- Ask Dr. Shulgin Online ARCHIVE: June 3, 2004
- Inhibition of plasma membrane monoamine transporters by β-ketoamphetamines. Nicholas V Cozzi, Michael KSievert, Alexander T Shulgin, Peyton JacobIII, Arnold Eruoho
- Schedules of Controlled Substances: Placement of Methylone Into Schedule I
- Bioanalysis of new designer drugs. Wohlfarth A, Weinmann W.
- New Psychoactive Substances (including synthetic cannabinoids, mephedrone, and more)
- Future Synthetic Drugs of Abuse. Donald A. Cooper. Drug Enforcement Administration McLean, Virginia
- Designer drugs: a medicinal chemistry perspective. F. Ivy Carroll Anita H. Lewin S. Wayne Mascarella Herbert H. Seltzman P. Anantha Reddy
- Synthetic cannabinoids in Europe
- Pharmacological Effects of MDMA in Man. By Enno Freye
- Drug Use in Relation to Outcome of Mammography Screening. von Euler-Chelpin M, Wu W, Vejborg and Lynge E
- DEA Drug Scheduling
- Electrophysiological Effects of Trace Amines on Mesencephalic Dopaminergic Neurons.Ada Ledonne, Nicola Berretta, Alessandro Davoli, Giada Ricciardo Rizzo, Giorgio Bernardi and Nicola Biagio Mercuri
- Electrophysiological evidence for a reciprocal interaction between amphetamine and cocaine-related drugs on rat midbrain dopaminergic neurons.Scarponi M, Bernardi G, Mercuri NB.
- Overdose of Drugs for Attention-Deficit Hyperactivity Disorder: Clinical Presentation, Mechanisms of Toxicity, and Management. Henry A. Spiller, author Hannah L. Hays Alfred Aleguas.
- Dose-dependent effectiveness of wheel running to attenuate cocaine-seeking: impact of sex and estrous cycle in rats. Peterson AB, Hivick DP, Lynch WJ.r.
- FDA Drug Safety Communication: Safety Review Update of Medications used to treat Attention-Deficit/Hyperactivity Disorder (ADHD) in children and young adults
- ADHD Medications and Risk of Serious Cardiovascular Events in Young and Middle-aged Adults
- Controlled Substances Act
- The Art of Drug Synthesis (Wiley Series on Drug Synthesis)
- Cannabis: domestic cultivation widespread
- A review of the influence of functional group modifications to the core scaffold of synthetic cathinones on drug pharmacokinetics
100g $390
out of stock
1kg $1690
1kg $1890
100mg $840
out of stock
1kg $1690
2kg $2900
500g $1700
100g $490